Newsletter

ISO 13485 is the international quality management standard and 21 CFR Part 820 is the U.S. legal requirement for organizations involved in the design, production, installation, and servicing of medical devices.  This training usually costs between $1050 – $3150 and is only offered in larger cluster cities, forcing companies not located in the area to … Read more

Lyle Hood, Ph.D., runs the Medical Design Innovations Laboratory at UTSA. He is dedicated to helping his students learn mechanical and biomedical engineering concepts and apply themselves to innovation. In 2020 (awarded in 2022), he received UTSA’s Innovator of the Year Award for 1 patent issued, 10 patent filings and 8 new technology disclosures in … Read more

Beyond antivirus software, protect your business in 2022. Ordinary anti-virus (AV) software will not protect your business from cyberattacks. As we head into 2022, ransomware in particular has grown into a global problem for businesses of all sizes. From the Colonial Pipeline ransomware attack to the more recent Kaseya cyberattack, everyone in the IT industry … Read more

BioMedSA is part of a nationwide network of similar organizations who leverage their members’ purchasing volume to pre-negotiate cost savings contracts with key suppliers. These pre-negotiated contracts are available to all BioMedSA members. In this post, we are pleased to feature PSC Biotech. They are a national company that has served over 100 clients in … Read more

Lauren Cornell, Ph.D., is the CEO of Novothelium, the Biofest Invest 2022 Best Pitch winner. She co-founded the company in 2015 to develop an acellular tissue-based product for nipple reconstruction, post mastectomy. Under her leadership, Novothelium has received other innovation and start-up awards, including: MassChallenge Platinum Award, TX A&M New Ventures 3rd Place Elevator Pitch, … Read more

BioMedSA’s Board of Directors approved 8 new memberships in March, 2022: MR3 Health, JANA Life Sciences, pH Partners, San Antonio Economic Development Corporation, NovoThelium, Vivifi Medical, Alt-Bionics, and T4 Movement. MR3 Health is a medical device startup producing a remote monitored foot sensor for patients with hypertension and diabetes to monitor the health of their … Read more

Biofest Invest 2022 was held on March 30, 2022, the day before the start of San Antonio’s Fiesta celebration. Over 250 people were registered in order to support medtech, biotech, digital health, and pharma entrepreneurs make connections with investors, support organizations, and colleagues, as well as receive helpful information to enable their growth.  Over 25 … Read more

BioMedSA is working on many new initiatives, supported by a move to our new office location in the San Antonio Technology Center. The Advocacy Advisory Board promoted the TRANSCEND Bill at the Texas Legislature, which would have created a program to support public investment in R&D for infectious diseases. The group has also been working … Read more

BioMedSA is part of a nationwide network of similar organizations who leverage their members’ purchasing volume to pre-negotiate cost savings contracts with key suppliers. These pre-negotiated contracts are available to all BioMedSA members. This month, we are pleased to feature CleanHarbors. CleanHarbors is one of the largest environmental services companies in North America, managing waste … Read more

Timothy J.C. Anderson, Ph.D., has been elected a fellow of the American Academy of Microbiology, based on his advancements and achievements in microbiology. An expert in malaria and schistosomiasis, he co-leads the Disease Intervention & Prevention program at Texas Biomedical Research Institute. He and his team were key to the identification of the first known … Read more